Calcium Channel Blocker, Drug Exposure

Simple item page
dc.contributor.advisorUtidjian, Levon
dc.contributor.authorUtidjian, Levon
dc.contributor.otherChildren's Hospital of Philadelphia
dc.date.accessioned2024-09-24T20:38:37Z
dc.date.available2024-06-10T19:03:22Z
dc.date.created2024-05-21
dc.descriptionThis medication concept set includes the following ingredients: Amlodipine, Diltiazem, Felodipine, Isradipine, Nicardipine, Nifedipine, Nisoldipine, and Verapamil. It also includes combinations of these ingredients with other antihypertensive medications. This code list was generated by taking the descendants of all the calcium channel blocker ingredients of interest and string matching the concept_name of the ingredient. Meds were expected to be only oral/enteral/IV, not topical, ophthalmic/ocular, or buccal.
dc.description.abstractThis broad concept set was intended to identify patients who received calcium channel blockers.
dc.identifier.urihttps://pedsnet.org/metadata/handle/20.500.14642/525.2
dc.provenancePreserving Kidney Function in Children with Chronic Kidney Disease (PRESERVE)
dc.publisherPEDSnet
dc.relation.urihttps://github.com/PRESERVE-Coordinating-Center/PRESERVE_Variables/blob/dfe52bdc48cfcfd6b358d4a424b5d39749554025/codesets/drug/rx_ccb_no_iv.csv
dc.rightsa CC-BY Attribution 4.0 License.
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectConcept Set Development::Content Data Model::PEDSnet Data Model
dc.subjectConcept Set Development::Content Data Model::PCORnet Data Model
dc.subjectConcept Set Development::Concept Set Development Strategy::Broad
dc.subjectConcept Set Development::Concept Set Evaluation::Clinician Reviewed
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Brand Pack Name
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Ingredient
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Precise Ingredient
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Multiple Ingredients
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug Component
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug Component
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug Form
dc.subjectConcept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug Form
dc.subject.meshCalcium Channel Blocker
dc.subject.meshCalcium Channel Agent
dc.subject.meshIon Channel or Pump Agent
dc.subject.meshCardiovascular Agent
dc.subject.otherNDC
dc.subject.otherRxNorm
dc.subject.otherRxNorm Extension
dc.titleCalcium Channel Blocker, Drug Exposure
dspace.entity.typeConceptSet
local.quality.statusResearch-Ready
local.subject.DataModelPEDSnet Data Model
local.subject.DataModelPCORnet Data Model
local.subject.EvalTypeClinician Reviewed
local.subject.MedTermCharBrand Pack Name
local.subject.MedTermCharIngredient
local.subject.MedTermCharPrecise Ingredient
local.subject.MedTermCharMultiple Ingredients
local.subject.MedTermCharSemantic Clinical Drug Component
local.subject.MedTermCharSemantic Branded Drug Component
local.subject.MedTermCharSemantic Branded Drug Form
local.subject.MedTermCharSemantic Clinical Drug Form
local.subject.flatBroad
relation.isStudyOfConceptSet6df51ca1-7a01-4551-b1f1-ca70aaf2c5ae
relation.isStudyOfConceptSet.latestForDiscovery6df51ca1-7a01-4551-b1f1-ca70aaf2c5ae

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
rx_ccb_no_iv_V2.csv
Size:
4.29 MB
Format:
Comma-Separated Values
Download

Domains

Medication Concept Sets

Version History

Now showing 1 - 2 of 2
VersionDateSummary
2*
 2024-09-24 16:37:53
This version does not contain IV formulations.
1
 2024-06-10 15:03:22
* Selected version